Published in Br J Ophthalmol on September 01, 2003
'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease. Nat Rev Rheumatol (2015) 1.99
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol (2009) 1.08
Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Clin Exp Immunol (2005) 1.01
Neuro-Behçet's disease: a report of sixteen patients. Neuropsychiatr Dis Treat (2010) 1.01
Behçet's Disease: an Insight from a Cardiologist's Point of View. Open Cardiovasc Med J (2010) 0.95
Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum Immunol (2006) 0.91
Behçet's Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity? Case Rep Med (2013) 0.89
Ischemic retinal vasculitis and its management. J Ophthalmol (2014) 0.86
HLA-B*51 the primary risk in Behçet disease. Proc Natl Acad Sci U S A (2014) 0.84
Periodontal Health Status among Patients with Behçet's Disease. Scientifica (Cairo) (2016) 0.82
Behcet's Disease: Is There Geographical Variation? A Review Far from the Silk Road. Int J Rheumatol (2015) 0.82
HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands. HLA (2016) 0.80
Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet's disease. Int Ophthalmol (2008) 0.79
Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio. Clin Rheumatol (2015) 0.77
Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behçet's Disease. PLoS One (2015) 0.77
New approaches in immunotherapy of behçet disease. Adv Pharm Bull (2013) 0.77
Epidemiology of Vasculitides in Khorasan Province, Iran. Iran J Med Sci (2015) 0.77
Topographic optic disc analysis by Heidelberg retinal tomography in ocular Behcet's disease. Br J Ophthalmol (2007) 0.77
Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol (2009) 0.76
Update on the diagnosis and management of Behçet's disease. Open Access Rheumatol (2014) 0.75
A 30-year-old female Behçet's disease patient with recurrent pleural and pericardial effusion and elevated adenosine deaminase levels: case report. J Thorac Dis (2016) 0.75
Assessment of genotoxicity associated with Behcet's disease using sister-chromatid exchange assay: vitamin E versus mitomycin C. Cytotechnology (2014) 0.75
Beçhet's disease: a rare cause of rectovaginal fistula. BMJ Case Rep (2010) 0.75
Genetic origin of Behçet's disease population in Denizli, Turkey; population genetics data analysis; historical demography and geographical perspectives based on β-globin gene cluster haplotype variation. Genes Immun (2016) 0.75
Polymorphisms of Promoter Region of TNF-α Gene in Iranian Azeri Turkish Patients with Behçet's Disease. J Korean Med Sci (2017) 0.75
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell (1997) 7.43
A candidate gene for familial Mediterranean fever. Nat Genet (1997) 7.17
A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1994) 3.33
Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet (2001) 2.95
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics (2001) 2.43
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol (1998) 2.10
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Description of Behçet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol (1956) 1.90
Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med (2003) 1.69
Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci (2000) 1.40
Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. Br J Rheumatol (1996) 1.35
The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol (1997) 1.32
Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis (2000) 1.27
Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today (1998) 1.26
Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum (1997) 1.21
Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology (1995) 1.18
MEFV mutations in Behçet's disease. Hum Mutat (2000) 1.13
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol (2000) 1.09
Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J (1997) 1.08
Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology (1999) 1.06
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm (2000) 1.05
Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis (2001) 1.05
Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol (2002) 1.05
Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum (2003) 1.05
Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease. Dermatology (1996) 1.04
Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J (1997) 1.04
The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int J Dermatol (1998) 1.03
A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet (2001) 1.02
Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol (1999) 1.00
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease. Am J Ophthalmol (1994) 0.98
Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm (1998) 0.95
Genetic anticipation in Behçet's syndrome. Ann Rheum Dis (1998) 0.94
Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol (1999) 0.94
Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome. Am J Clin Pathol (2001) 0.94
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
The incidence and pathology of conjunctival ulceration in Behçet's syndrome. Br J Ophthalmol (2002) 0.92
Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol (2000) 0.91
HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet's disease. Tissue Antigens (2001) 0.90
HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients. Hum Immunol (2001) 0.90
Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int (1999) 0.89
Immunopathologic study of the conjunctiva in patients with behçet disease. Ophthalmology (1995) 0.88
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet (2000) 0.87
Association of factor V Leiden with Behçet's disease. J Rheumatol (1997) 0.86
A weak association of HLA-B*2702 with Behçet's disease. Genes Immun (2002) 0.86
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease. Ann Rheum Dis (2002) 0.86
Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int (1999) 0.85
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease. J Rheumatol (2001) 0.85
Ocular and neurological Behçet's disease without orogenital ulceration? J Neurol Neurosurg Psychiatry (1993) 0.82
RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. Invest Ophthalmol Vis Sci (1992) 0.80
Soluble adhesion molecules in Behçet's disease. Ocul Immunol Inflamm (1998) 0.79
Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease. Br J Ophthalmol (2000) 0.78
Effect of interferon-alpha(2a) on neutrophil adhesion and phagocytosis in chronic myeloid leukemia and Behçet's disease. Clin Rheumatol (2002) 0.77
Amyloidosis in Behçet's disease and familial Mediterranean fever. Rheumatology (Oxford) (2002) 0.76
Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease. Ocul Immunol Inflamm (1998) 0.76
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet (1991) 1.76
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
A non-HLA gene within the MHC in psoriasis. Lancet (1999) 1.67
Questioning questionnaires. Eye (Lond) (2001) 1.58
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Immune exclusion and mucus trapping during the rapid expulsion of Nippostrongylus brasiliensis from primed rats. Immunology (1981) 1.56
Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci (Lond) (1990) 1.49
HLA-DR4 may determine expression of actinic prurigo in British patients. J Invest Dermatol (1996) 1.44
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost (2001) 1.41
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
Genetic markers in narcolepsy. Lancet (1984) 1.38
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics (2001) 1.35
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Transformation of lymphocytes from patients awaiting cadaver renal transplants. Lancet (1976) 1.32
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun (2002) 1.22
SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex. Immunogenetics (2004) 1.15
Precision and accuracy of intraoperative temperature monitoring. Anesth Analg (1983) 1.13
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Genetic influence on peripheral blood T lymphocyte levels. Genes Immun (2000) 1.06
Ventricular arrhythmias after topical vasoconstrictors. Anesth Analg (1973) 1.06
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations. Am J Hum Genet (2002) 1.03
Genetic determinism in the relationship between human CD4+ and CD8+ T lymphocyte populations? Genes Immun (2001) 1.03
HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. Hum Immunol (1992) 1.03
Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol (1999) 1.01
A British ophthalmological surveillance unit. British Ophthalmological Surveillance Unit Steering Committee. Br J Ophthalmol (1997) 1.01
IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Transplantation (1995) 1.01
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology (1992) 0.99
Postoperative hypoxemia in obese patients. Ann Surg (1974) 0.98
Ultrasonic localization of the lumbar epidural space. Anesthesiology (1980) 0.98
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol (1996) 0.98
Streptococcus anginosus-associated endogenous endophthalmitis mimicking fungal endophthalmitis. J Clin Microbiol (2005) 0.98
Acute retinal necrosis in children caused by herpes simplex virus. Retina (2001) 0.98
Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int (1997) 0.98
Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms. Immunogenetics (1988) 0.97
Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease. Clin Exp Immunol (1986) 0.96
Postoperative hypothermia in adults: relationship of age, anesthesia, and shivering to rewarming. Anesth Analg (1981) 0.95
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol (1995) 0.95
Resolution of calcific band keratopathy after lowering elevated serum calcium in a patient with sarcoidosis. Br J Ophthalmol (1995) 0.95
Awareness, dreams, and hallucinations associated with general anesthesia. Anesth Analg (1975) 0.93
HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J Rheumatol (1990) 0.93
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol (1994) 0.91
HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum (1992) 0.91
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye (Lond) (1994) 0.90
Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol (2007) 0.90
Volume and pH of gastric juice in obese patients. Anesthesiology (1975) 0.90
The association of DNA variants at or near the IgH locus with rheumatoid arthritis. J Immunogenet (1988) 0.90
Part I: cardiopulmonary consequences of morbid obesity. Life Sci (1980) 0.90
Systemic associations of retinal vasculitis. Int Ophthalmol Clin (1991) 0.89
Macular ischaemia in posterior uveitis. Eye (Lond) (1993) 0.89
A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol (2001) 0.88
The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin Exp Immunol (1999) 0.88
Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study. Eye (Lond) (1997) 0.88
Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Br J Ophthalmol (2004) 0.88
Postoperative arterial blood gas measurement in obese patients: effect of position on gas exchange. Ann Surg (1975) 0.87
HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics (1989) 0.87
Immunoglobulin (Gm) allotype frequencies in patients with renal failure. Transplantation (1982) 0.87
The effect of massive weight loss on arterial oxygenation and pulmonary function tests. Anesthesiology (1981) 0.87
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet (2000) 0.87
Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye (Lond) (1996) 0.86
Behçet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol (2003) 0.86
Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol (2005) 0.86
Tuberculous orbital apex syndromes. Br J Ophthalmol (2008) 0.86
Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens (2004) 0.86
Neovascularisation associated with posterior uveitis. Br J Ophthalmol (1987) 0.85
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J Neuroimmunol (2004) 0.85
Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Tissue Antigens (2005) 0.85